ClinicalTrials.gg
Status unknownNCT03452800Updated Jul 10, 2018

Addiction Among Mental Health Professionals

An observational study in Addiction, sponsored by University Hospital, Strasbourg, France. Status unknown at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-07-10.

Sponsored by University Hospital, Strasbourg, France · Observational

The sponsor has not verified this record recently (last verified Feb 2018), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Other
Enrollment
32
Ages
18 Years and older
Sex
All
01

Study summary

Our goal is to determine the representations of addiction among caregivers working in the field of mental health. We hypothesize that caregivers, despite their investment in care, have a negative social representation of patients suffering from addictive disorders, which could be related to a lack of training on the pathology and its social repercussions.

02

Conditions studied

  • Addiction

Keywords

  • addiction
  • mental health
03

In context

Behavior, Addictive

521 studies on the registry are indexed under Behavior, Addictive; 124 are open to participants now.

This study's planned enrollment of 32 is below the median of 158 across 106 observational studies indexed under Behavior, Addictive.

Browse Behavior, Addictive studies →

Lead sponsor

University Hospital, Strasbourg, France is the lead sponsor of 999 studies on the registry; 358 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Health professional with more than 5 years of professional experience in the field of management of mental illnesses

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age greater than or equal to 18 years
  • Health professional with more than 5 years of professional experience in the field of management of mental illnesses
  • Health professional having accepted to participate in the study

Exclusion criteria

Exclusion Criteria:

  • Refusal to participate in the stud
05

Study design

Observational model
Cohort
Time perspective
Other
Enrollment
32 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Number of addictions

    Time frame: Period from 5 years of professional experience will be examined

07

Study locations

1 of 1 sites recruiting
  • Service de Psychiatrie 1
    Strasbourg, 67091, France
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2018 (actual). Primary completion is estimated for Oct 2018, 8 months after the start.

Of 46 non-industry observational studies under Behavior, Addictive, half reached primary completion within 40 months of starting (the median), counting those still running; a quarter within 20 and three quarters within 111. This study's planned 8 months is below that.

Counting every sponsor, half of 49 studies reached it within 40 months; a quarter within 20 and three quarters within 73.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 26, 2018
First posted
Mar 2, 2018
StartActual
Feb 1, 2018
Primary completionEst.
Oct 2018
CompletionEst.
Oct 2018
Last update
Jul 10, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 10, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03452800
Responsible party
Sponsor
First posted
Mar 2, 2018
Start date
Feb 1, 2018
Primary completion
Oct 2018 (estimated)
Completion
Oct 2018 (estimated)
Last update
Jul 10, 2018

Study contacts

Laurence LALANNE-TONGIO, MD
Contact
laurence.lalanne@chru-strasbourg.fr
33 3 88 11 66 65
Elisa LOCATELLI, MD
Contact
elisalocatelli00@gmail.com
33 3 88 11 66 65
Laurence LALANNE-TONGIO, MD
study director · University Hospital, Strasbourg, France

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Feb 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion